Vericel Corp
For the period ended Sep 30, 2024. Filed Nov 7, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2024 · Filed Nov 7, 2024
VCEL$59.03+1.1%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Cash Flows
| Nine Months Ended September 30, | ||
|---|---|---|
| 2024 | 2023 | |
| Operating activities: | ||
| Net loss | $(9,445) | $(16,175) |
| Adjustments to reconcile net loss to net cash flows from operating activities: | ||
| Depreciation and amortization expense | 4,027 | 3,483 |
| Stock-based compensation expense | 28,578 | 25,416 |
| Amortization of premiums and discounts on marketable securities | (542) | (788) |
| Amortization of debt issuance costs | 161 | 161 |
| Non-cash lease costs | 5,139 | 4,291 |
| Other | 25 | 18 |
| Changes in operating assets and liabilities: | ||
| Inventory | (2,669) | 3,365 |
| Accounts receivable | 9,877 | 6,810 |
| Other current assets | (1,029) | (627) |
| Accounts payable | (1,639) | 360 |
| Accrued expenses | (2,887) | (2,562) |
| Operating lease liabilities | 6,182 | 1,408 |
| Other non-current assets and liabilities, net | 143 | 65 |
| Net cash provided by operating activities | 35,921 | 25,225 |
| Investing activities: | ||
| Purchases of investments | (52,612) | (36,254) |
| Sales and maturities of investments | 38,416 | 60,890 |
| Expenditures for property and equipment | (50,187) | (12,178) |
| Purchases of intangible assets | — | (7,500) |
| Net cash (used in) provided by investing activities | (64,383) | 4,958 |
| Financing activities: | ||
| Net proceeds from common stock issuance | 17,255 | 4,614 |
| Payments on employee’s behalf for taxes related to vesting of restricted stock unit awards | (5,309) | (2,262) |
| Other | — | (41) |
| Net cash provided by financing activities | 11,946 | 2,311 |
| Net (decrease) increase in cash, cash equivalents, and restricted cash | (16,516) | 32,494 |
| Cash, cash equivalents, and restricted cash at beginning of period | 86,866 | 51,067 |
| Cash, cash equivalents, and restricted cash at end of period | $70,350 | $83,561 |
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (CONTINUED)
| Nine Months Ended September 30, | ||
|---|---|---|
| 2024 | 2023 | |
| Supplemental disclosure of cash flow information: | ||
| Non-cash information: | ||
| Right-of-use asset and lease liability recognized | $3,238 | $36,022 |
| Additions to property and equipment included in accounts payable | 10,301 | 5,568 |
| Nine Months Ended September 30, | ||
|---|---|---|
| 2024 | 2023 | |
| Reconciliation to amounts within the condensed consolidated balance sheets: | ||
| Cash and cash equivalents | $53,681 | $60,473 |
| Restricted cash | 16,669 | 23,088 |
| Total cash, cash equivalents, and restricted cash at end of period | $70,350 | $83,561 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.